Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-03-06 @ 6:23 PM
Study NCT ID:
NCT02316834
Status:
COMPLETED
Last Update Posted:
2022-02-24
First Post:
2014-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Fallopian Tube Serous Adenocarcinoma | View |
| None | High Grade Ovarian Serous Adenocarcinoma | View |
| None | Ovarian Mass | View |
| None | Primary Peritoneal Serous Adenocarcinoma | View |
| None | Stage III Fallopian Tube Cancer AJCC v7 | View |
| None | Stage III Ovarian Cancer AJCC v6 and v7 | View |
| None | Stage III Primary Peritoneal Cancer AJCC v7 | View |
| None | Stage IIIA Fallopian Tube Cancer AJCC v7 | View |
| None | Stage IIIA Ovarian Cancer AJCC v6 and v7 | View |
| None | Stage IIIA Primary Peritoneal Cancer AJCC v7 | View |
| None | Stage IIIB Fallopian Tube Cancer AJCC v7 | View |
| None | Stage IIIB Ovarian Cancer AJCC v6 and v7 | View |
| None | Stage IIIB Primary Peritoneal Cancer AJCC v7 | View |
| None | Stage IIIC Fallopian Tube Cancer AJCC v7 | View |
| None | Stage IIIC Ovarian Cancer AJCC v6 and v7 | View |
| None | Stage IIIC Primary Peritoneal Cancer AJCC v7 | View |
| None | Stage IV Fallopian Tube Cancer AJCC v6 and v7 | View |
| None | Stage IV Ovarian Cancer AJCC v6 and v7 | View |
| None | Stage IV Primary Peritoneal Cancer AJCC v7 | View |
Keywords: